Knight TE, Ahn KW, Hebert KM, Atshan R, et al. No impact of CD34(+) cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma. Bone Marrow Transplant 2023 Sep 4. doi: 10.1038/s41409-023-02092.
PMID: 37666957